| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.8M | -10.1% |
| Cost of Revenue | $5.1M | +81.9% |
| Gross Profit | $5.7M | -38.1% |
| R&D Expense | $49.8M | -5.7% |
| SG&A Expense | $24.5M | -11.8% |
| Operating Income | -$68.5M | +5.2% |
| Pre-tax Income | -$201.0M | -167.6% |
| Income Tax | $0 | — |
| Net Income | -$201.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $67.7M | +216.4% |
| Accounts Receivable | $2.4M | -51.7% |
| Current Assets | $206.8M | +92.0% |
| Total Assets | $284.8M | +78.1% |
| Current Liabilities | $11.9M | -59.2% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $158.2M | +214.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.6M | -0.1% |
| Capital Expenditures | $11.1M | +22.5% |
| Investing Cash Flow | -$78.4M | — |
| Financing Cash Flow | $175.5M | +1226.2% |
| Free Cash Flow | -$61.7M | -3.5% |
| -167.6% |
| EPS (Basic) | -$1.09 | -91.2% |
| EPS (Diluted) | -$1.09 | -91.2% |
| Stockholders' Equity |
| $126.6M |
| +15.5% |